Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)

Couillard S., Do WIH., Beasley R., Hinks TSC., Pavord ID.

DOI

10.1183/23120541.00570-2021

Type

Journal article

Journal

ERJ Open Research

Publisher

European Respiratory Society (ERS)

Publication Date

20/01/2022

Pages

00570 - 2021

Permalink Original publication